MY101916A - Etoposide oral dosage form. - Google Patents

Etoposide oral dosage form.

Info

Publication number
MY101916A
MY101916A MYPI87002211A MYPI19872211A MY101916A MY 101916 A MY101916 A MY 101916A MY PI87002211 A MYPI87002211 A MY PI87002211A MY PI19872211 A MYPI19872211 A MY PI19872211A MY 101916 A MY101916 A MY 101916A
Authority
MY
Malaysia
Prior art keywords
dosage form
oral dosage
etoposide
etoposide oral
administered
Prior art date
Application number
MYPI87002211A
Other languages
English (en)
Inventor
Begum Selima
Ullah Ismat
C Nunning Bernard
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MY101916A publication Critical patent/MY101916A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MYPI87002211A 1984-03-19 1987-09-29 Etoposide oral dosage form. MY101916A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19
GB08506943A GB2155789B (en) 1984-03-19 1985-03-18 Etoposide capsules

Publications (1)

Publication Number Publication Date
MY101916A true MY101916A (en) 1992-02-15

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002211A MY101916A (en) 1984-03-19 1987-09-29 Etoposide oral dosage form.

Country Status (28)

Country Link
JP (1) JPS60209516A (no)
KR (1) KR850006136A (no)
AT (1) AT392904B (no)
AU (1) AU571308B2 (no)
BE (1) BE901963A (no)
CA (1) CA1238578A (no)
CH (1) CH662731A5 (no)
DE (1) DE3509741A1 (no)
DK (1) DK164535C (no)
EG (1) EG17521A (no)
ES (1) ES8702140A1 (no)
FI (1) FI84023C (no)
FR (1) FR2561104B1 (no)
GB (1) GB2155789B (no)
GR (1) GR850688B (no)
IE (1) IE58340B1 (no)
IL (1) IL74615A (no)
IT (1) IT1187640B (no)
LU (1) LU85812A1 (no)
MY (1) MY101916A (no)
NL (1) NL8500739A (no)
NO (1) NO170569C (no)
NZ (1) NZ211078A (no)
OA (1) OA07968A (no)
PT (1) PT80131B (no)
SE (1) SE8501312L (no)
YU (1) YU45243B (no)
ZA (1) ZA851935B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (no) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
NO851022L (no) 1985-09-20
IL74615A (en) 1988-07-31
DK122285D0 (da) 1985-03-18
DK122285A (da) 1985-09-20
NO170569B (no) 1992-07-27
GB8506943D0 (en) 1985-04-24
JPS60209516A (ja) 1985-10-22
IT1187640B (it) 1987-12-23
IT8519897A0 (it) 1985-03-14
PT80131A (en) 1985-04-01
PT80131B (pt) 1987-10-20
GB2155789B (en) 1987-10-21
AT392904B (de) 1991-07-10
NZ211078A (en) 1987-08-31
DK164535C (da) 1992-11-30
ZA851935B (en) 1985-10-30
FI851040A0 (fi) 1985-03-15
GB2155789A (en) 1985-10-02
FR2561104A1 (fr) 1985-09-20
NO170569C (no) 1992-11-04
SE8501312D0 (sv) 1985-03-18
FI84023B (fi) 1991-06-28
GR850688B (no) 1985-07-08
DE3509741A1 (de) 1985-09-26
SE8501312L (sv) 1985-09-20
ES541370A0 (es) 1986-12-16
FR2561104B1 (fr) 1988-04-08
ATA81985A (de) 1990-12-15
IE850686L (en) 1985-09-19
FI851040L (fi) 1985-09-20
FI84023C (fi) 1991-10-10
YU42085A (en) 1988-02-29
EG17521A (en) 1990-06-30
CH662731A5 (de) 1987-10-30
IL74615A0 (en) 1985-06-30
AU3897585A (en) 1985-09-26
NL8500739A (nl) 1985-10-16
AU571308B2 (en) 1988-04-14
LU85812A1 (fr) 1985-12-12
ES8702140A1 (es) 1986-12-16
BE901963A (fr) 1985-09-18
YU45243B (en) 1992-05-28
IE58340B1 (en) 1993-09-08
OA07968A (fr) 1987-01-31
DK164535B (da) 1992-07-13
CA1238578A (en) 1988-06-28
KR850006136A (ko) 1985-10-02

Similar Documents

Publication Publication Date Title
GR900100659A (en) Dosage form for administering oral hupoglycemic glipizide
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
MY8600471A (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
GB8618466D0 (en) Administering medicaments to patients
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
MY101916A (en) Etoposide oral dosage form.
DE3568944D1 (en) Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition
IT8548306A0 (it) Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare
IL79207A (en) Geriatric pharmaceutical compositions containing terguride for treatment of cognitive and psychic disorders due to dopamine hypofunction
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
HK44184A (en) Pharmaceutical preparation for administration to the mucosa of the oral or nasal cavity
GB8525067D0 (en) Administering medicaments to patients
GB8519141D0 (en) Administering medicaments to patients